BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 21868380)

  • 1. Substrate sequence influences γ-secretase modulator activity, role of the transmembrane domain of the amyloid precursor protein.
    Sagi SA; Lessard CB; Winden KD; Maruyama H; Koo JC; Weggen S; Kukar TL; Golde TE; Koo EH
    J Biol Chem; 2011 Nov; 286(46):39794-803. PubMed ID: 21868380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Second generation γ-secretase modulators exhibit different modulation of Notch β and Aβ production.
    Wanngren J; Ottervald J; Parpal S; Portelius E; Strömberg K; Borgegård T; Klintenberg R; Juréus A; Blomqvist J; Blennow K; Zetterberg H; Lundkvist J; Rosqvist S; Karlström H
    J Biol Chem; 2012 Sep; 287(39):32640-50. PubMed ID: 22851182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First and second generation γ-secretase modulators (GSMs) modulate amyloid-β (Aβ) peptide production through different mechanisms.
    Borgegard T; Juréus A; Olsson F; Rosqvist S; Sabirsh A; Rotticci D; Paulsen K; Klintenberg R; Yan H; Waldman M; Stromberg K; Nord J; Johansson J; Regner A; Parpal S; Malinowsky D; Radesater AC; Li T; Singh R; Eriksson H; Lundkvist J
    J Biol Chem; 2012 Apr; 287(15):11810-9. PubMed ID: 22334705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amyloid beta 42 peptide (Abeta42)-lowering compounds directly bind to Abeta and interfere with amyloid precursor protein (APP) transmembrane dimerization.
    Richter L; Munter LM; Ness J; Hildebrand PW; Dasari M; Unterreitmeier S; Bulic B; Beyermann M; Gust R; Reif B; Weggen S; Langosch D; Multhaup G
    Proc Natl Acad Sci U S A; 2010 Aug; 107(33):14597-602. PubMed ID: 20679249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abeta42-lowering nonsteroidal anti-inflammatory drugs preserve intramembrane cleavage of the amyloid precursor protein (APP) and ErbB-4 receptor and signaling through the APP intracellular domain.
    Weggen S; Eriksen JL; Sagi SA; Pietrzik CU; Golde TE; Koo EH
    J Biol Chem; 2003 Aug; 278(33):30748-54. PubMed ID: 12777371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of sulindac sulfide on the membrane architecture and the activity of gamma-secretase.
    Gamerdinger M; Clement AB; Behl C
    Neuropharmacology; 2008 May; 54(6):998-1005. PubMed ID: 18359496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. γ-Secretase Modulators and APH1 Isoforms Modulate γ-Secretase Cleavage but Not Position of ε-Cleavage of the Amyloid Precursor Protein (APP).
    Lessard CB; Cottrell BA; Maruyama H; Suresh S; Golde TE; Koo EH
    PLoS One; 2015; 10(12):e0144758. PubMed ID: 26678856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An NSAID-like compound, FT-9, preferentially inhibits gamma-secretase cleavage of the amyloid precursor protein compared to its effect on amyloid precursor-like protein 1.
    Sala Frigerio C; Kukar TL; Fauq A; Engel PC; Golde TE; Walsh DM
    Biochemistry; 2009 Nov; 48(46):10894-904. PubMed ID: 19821615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-amyloid precursor protein mutants respond to gamma-secretase modulators.
    Page RM; Gutsmiedl A; Fukumori A; Winkler E; Haass C; Steiner H
    J Biol Chem; 2010 Jun; 285(23):17798-810. PubMed ID: 20348104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substrate determinants in the C99 juxtamembrane domains differentially affect γ-secretase cleavage specificity and modulator pharmacology.
    Ousson S; Saric A; Baguet A; Losberger C; Genoud S; Vilbois F; Permanne B; Hussain I; Beher D
    J Neurochem; 2013 May; 125(4):610-9. PubMed ID: 23253155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substrate-targeting gamma-secretase modulators.
    Kukar TL; Ladd TB; Bann MA; Fraering PC; Narlawar R; Maharvi GM; Healy B; Chapman R; Welzel AT; Price RW; Moore B; Rangachari V; Cusack B; Eriksen J; Jansen-West K; Verbeeck C; Yager D; Eckman C; Ye W; Sagi S; Cottrell BA; Torpey J; Rosenberry TL; Fauq A; Wolfe MS; Schmidt B; Walsh DM; Koo EH; Golde TE
    Nature; 2008 Jun; 453(7197):925-9. PubMed ID: 18548070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NSAID-based γ-secretase modulators do not bind to the amyloid-β polypeptide.
    Barrett PJ; Sanders CR; Kaufman SA; Michelsen K; Jordan JB
    Biochemistry; 2011 Nov; 50(47):10328-42. PubMed ID: 21995415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complex relationships between substrate sequence and sensitivity to alterations in γ-secretase processivity induced by γ-secretase modulators.
    Jung JI; Ran Y; Cruz PE; Rosario AM; Ladd TB; Kukar TL; Koo EH; Felsenstein KM; Golde TE
    Biochemistry; 2014 Apr; 53(12):1947-57. PubMed ID: 24620716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Important functional role of residue x of the presenilin GxGD protease active site motif for APP substrate cleavage specificity and substrate selectivity of γ-secretase.
    Kretner B; Fukumori A; Kuhn PH; Pérez-Revuelta BI; Lichtenthaler SF; Haass C; Steiner H
    J Neurochem; 2013 Apr; 125(1):144-56. PubMed ID: 23237322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rac1 changes the substrate specificity of gamma-secretase between amyloid precursor protein and Notch1.
    Boo JH; Sohn JH; Kim JE; Song H; Mook-Jung I
    Biochem Biophys Res Commun; 2008 Aug; 372(4):913-7. PubMed ID: 18538664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. γ-Secretase modulators exhibit selectivity for modulation of APP cleavage but inverse γ-secretase modulators do not.
    Lessard CB; Rodriguez E; Ladd TB; Minter LM; Osborne BA; Miele L; Golde TE; Ran Y
    Alzheimers Res Ther; 2020 May; 12(1):61. PubMed ID: 32430033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantification of gamma-secretase modulation differentiates inhibitor compound selectivity between two substrates Notch and amyloid precursor protein.
    Yang T; Arslanova D; Gu Y; Augelli-Szafran C; Xia W
    Mol Brain; 2008 Nov; 1():15. PubMed ID: 18983676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and mechanism of γ-secretase modulators for Alzheimer's disease.
    Crump CJ; Johnson DS; Li YM
    Biochemistry; 2013 May; 52(19):3197-216. PubMed ID: 23614767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potent γ-secretase inhibitors/modulators interact with amyloid-β fibrils but do not inhibit fibrillation: a high-resolution NMR study.
    Yesuvadian R; Krishnamoorthy J; Ramamoorthy A; Bhunia A
    Biochem Biophys Res Commun; 2014 May; 447(4):590-5. PubMed ID: 24747079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteolysis of chimeric beta-amyloid precursor proteins containing the Notch transmembrane domain yields amyloid beta-like peptides.
    Zhang J; Ye W; Wang R; Wolfe MS; Greenberg BD; Selkoe DJ
    J Biol Chem; 2002 Apr; 277(17):15069-75. PubMed ID: 11839734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.